OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDT

          OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDTSeptember 19, 2025 7:40 AM EDT | Source: OS TherapiesNew York, New York--(Newsfile Corp. - September 19, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has been invited to participate in the "Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeut ...